학술논문

Patterns of antibiotic use, pathogens, and prediction of mortality in hospitalized neonates and young infants with sepsis: A global neonatal sepsis observational cohort study (NeoOBS).
Document Type
article
Author
Neal J RussellWolfgang StöhrNishad PlakkalAislinn CookJames A BerkleyBethou AdhisivamRamesh AgarwalNawshad Uddin AhmedManica BalasegaramDaynia BallotAdrie BekkerEitan Naaman BerezinDavide BilardiSuppawat BoonkasidechaCristina G CarvalheiroNeema ChamiSuman ChaurasiaSara ChiurchiuViviane Rinaldi Favarin ColasSimon CousensTim R CresseyAna Carolina Dantas de AssisTran Minh DienYijun DingNguyen Trong DungHan DongAngela DramowskiMadhusudhan DsAjay DudejaJinxing FengYouri GlupczynskiSrishti GoelHerman GoossensDoan Thi Huong HaoMahmudul Islam KhanTatiana Munera HuertasMohammad Shahidul IslamDaniel JarovskyNathalie KhavessianMeera KhoranaAngeliki KontouTomislav KostyanevPremsak LaoyookhonSorasak LochindaratMattias LarssonMaia De LucaSurbhi Malhotra-KumarNivedita MondalNitu MundhraPhilippa MusokeMarisa M Mussi-PinhataRuchi NanavatiFirdose NakwaSushma NangiaJolly NankundaAlessandra NardoneBorna NyaokeChristina W ObieroMaxensia OworWang PingKanchana PreedisripipatShamim QaziLifeng QiTanusha RamdinAmy RiddellLorenza RomaniPraewpan RoysuwanRobin SaggersEmmanuel RoilidesSamir K SahaKosmas SarafidisValerie TusubiraReenu ThomasSithembiso VelaphiTuba VilkenXiaojiao WangYajuan WangYonghong YangLiu ZunjieSally EllisJulia A BielickiA Sarah WalkerPaul T HeathMike Sharland
Source
PLoS Medicine, Vol 20, Iss 6, p e1004179 (2023)
Subject
Medicine
Language
English
ISSN
1549-1277
1549-1676
Abstract
BackgroundThere is limited data on antibiotic treatment in hospitalized neonates in low- and middle-income countries (LMICs). We aimed to describe patterns of antibiotic use, pathogens, and clinical outcomes, and to develop a severity score predicting mortality in neonatal sepsis to inform future clinical trial design.Methods and findingsHospitalized infants ConclusionAntibiotic regimens used in neonatal sepsis commonly diverge from WHO guidelines, and trials of novel empiric regimens are urgently needed in the context of increasing antimicrobial resistance (AMR). The baseline NeoSep Severity Score identifies high mortality risk criteria for trial entry, while the NeoSep Recovery Score can help guide decisions on regimen change. NeoOBS data informed the NeoSep1 antibiotic trial (ISRCTN48721236), which aims to identify novel first- and second-line empiric antibiotic regimens for neonatal sepsis.Trial registrationClinicalTrials.gov, (NCT03721302).